netFormulary
 Report : A-Z NHS England items in Formulary 17/06/2021 21:40:22
[Back]
 
Section Status NHS England Name
08.01.05 Formulary MHS England Abemaciclib Verzenios
08.03.04.02 Formulary MHS England Abiraterone Zytiga
01.05.03 Formulary MHS England Adalimumab 
10.01.03 Formulary MHS England Adalimumab 
13.05.03 Formulary MHS England Adalimumab 
08.01.05 Formulary MHS England Afatinib Giotrif
09.08.01 Restricted Use MHS England Agalsidase Alfa and Beta Fabrazyme
09.08.01 Restricted Use MHS England Agalsidase Alfa and Beta Replagal
08.02.04 Non Formulary MHS England Aldesleukin Proleukin
08.01.05 Formulary MHS England Alectinib Alecensa
08.02.03 Formulary MHS England Alemtuzumab Lemtrada
08.02.03 Formulary MHS England Alemtuzumab MabCampath
09.08.01 Restricted Use MHS England Alglucosidase Alfa Myozyme
02.05.01 Non Formulary MHS England Ambrisentan 
05.01.04 Formulary MHS England Amikacin 
05.02 Formulary MHS England Amphotericin AmBisome
10.01.03 Formulary MHS England Anakinra 
08.03.04.01 Formulary MHS England Anastrozole 
05.02.04 Formulary MHS England Anidulafungin Ecalta
08.02.02 Non Formulary MHS England Antithymocyte immunoglobulin (rabbit)  Thymoglobuline
08.01.05 Formulary MHS England Arsenic Trioxide Trisenox
10.02 Formulary MHS England Ataluren 
10.04 Formulary MHS England Ataluren 
08.01.05 Formulary MHS England Atezolizumab Tecentriq
08.01.05 Formulary MHS England Avelumab Bavencio
08.01.05 Formulary MHS England Axitinib Inlyta
08.01.03 Formulary MHS England Azacitidine Vidaza
08.02.01 Formulary MHS England Azathioprine 
08.02.02 Formulary MHS England Basiliximab Simulect
08.01 Non Formulary MHS England Begelomab Begedina
08.02.02 Non Formulary MHS England Belatacept Nulojix
10.01 Formulary MHS England Belimumab 
08.01.01 Formulary MHS England Bendamustine 
08.01.05 Formulary MHS England Binimetinib Mektovi
09.08.01 Formulary MHS England Biotin 
08.01.02 Formulary MHS England Bleomycin 
08.02 Formulary MHS England Blinatumomab Blincyto
02.05.01 Formulary MHS England Bosentan 
08.01.05 Formulary MHS England Bosutinib Bosulif
08.01.05 Formulary MHS England Brentuximab vedotin Adcetris
08.01.05 Formulary MHS England Brigatinib Alunbrig
08.01.01 Formulary MHS England Busulfan 
08.01.05 Formulary MHS England Cabazitaxel Jevtana
08.01.05 Formulary MHS England Cabozantinib Cometriq
08.01.05 Formulary MHS England Cabozantinib Cabometyx Cometriq
08.01 Formulary MHS England Calcium Folinate 
08.01 Formulary MHS England Calcium Levofolinate 
08.02.04 Non Formulary MHS England Canakinumab Ilaris
04.08.01 Non Formulary MHS England Cannabidiol Epidiolex
08.01.03 Formulary MHS England Capecitabine 
08.01.05 Formulary MHS England Carboplatin 
08.01.05 Formulary MHS England Carboplatin Paraplatin
08.01.05 Formulary MHS England Carfilzomib Kyprolis
08.01.01 Non Formulary MHS England Carmustine BiCNU
08.01.01 Formulary MHS England Carmustine 
08.01.05 Formulary MHS England Ceritinib Zykadia
08.01.05 Formulary MHS England Cetuximab Erbitux
08.01.01 Formulary MHS England Chlorambucil 
08.02.02 Formulary MHS England Ciclosporin 
09.05.01.02 Formulary MHS England Cinacalcet 
08.01.05 Formulary MHS England Cisplatin 
08.01.03 Formulary MHS England Cladribine LeustakLitak
08.02.04 Non Formulary MHS England Cladribine Mavenclad
05.01.07 Formulary MHS England Colistimethate for nebulisation Colomycin
08.01.05 Formulary MHS England Crisantaspase Erwinase
08.01.05 Formulary MHS England Crizotinib Xalkori
08.01.01 Formulary MHS England Cyclophosphamide 
08.01.03 Formulary MHS England Cytarabine Depocyte
08.01.05 Formulary MHS England Dabrafenib Tafinlar
08.01.05 Formulary MHS England Dacarbazine 
08.01.05 Formulary MHS England Dacomitinib Vizimpro
08.01.05 Formulary MHS England Daratumumab Darzalex
08.03.04.02 Formulary MHS England Darolutamide Nubeqa
08.01.05 Formulary MHS England Dasatinib Sprycel
08.01.02 Formulary MHS England Daunorubicin 
09.01.03 Formulary MHS England Deferasirox Exjade
02.11 Non Formulary MHS England Defibrotide Injection 200 mg 
09.01.03 Formulary MHS England Desferrioxamine Mesilate Desferal
08.01 Formulary MHS England Dexrazoxane Savene
08.01 Formulary MHS England Dexrazoxane Cardioxane
08.02.04 Formulary MHS England Dimethyl fumarate Tecfidera
08.02.04 Non Formulary MHS England Dinutuximab Unituxin
08.01.05 Formulary MHS England Docetaxel Taxotere
03.07 Formulary MHS England Dornase Alfa 
08.01.02 Formulary MHS England Doxorubicin Caelyx ,
Myocet
08.01.05 Formulary MHS England Durvalumab Imfinzi
09.01.03 Non Formulary MHS England Eculizumab 
08.01.05 Formulary MHS England Encorafenib Braftovi
08.01.05 Formulary MHS England Entrectinib 
08.01.02 Formulary MHS England Epirubicin 2mg/ml
02.08.01 Formulary MHS England Epoprostenol 
08.01.05 Formulary MHS England Eribulin Halaven
08.01.05 Non Formulary MHS England Erlotinib Tarceva
08.01.05 Formulary MHS England Erlotinib Tarceva
08.01.05 Non Formulary MHS England Erlotinib Tarceva
08.01.04 Formulary MHS England Etoposide Etopophos Vepesid
08.01.05 Formulary MHS England Everolimus Afinitor
08.01.05 Formulary MHS England Everolimus Votubia
08.02.02 Non Formulary MHS England Everolimus Certican
02.11 Restricted Use MHS England Factor IX Fraction, Dried 
02.11 Restricted Use MHS England Factor VIII Fraction, Dried 
02.11 Restricted Use MHS England Factor XIII Fraction, Dried 
08.02.04 Non Formulary MHS England Fampridine 
08.02.04 Formulary MHS England Fingolimod 
08.01.03 Formulary MHS England Fludarabine Phosphate Fludara
08.01.03 Formulary MHS England Fluorouracil 
05.03.02.02 Formulary MHS England Ganciclovir 
08.01.05 Formulary MHS England Gefitinib Iressa
08.01.03 Formulary MHS England Gemcitabine Gemzar
08.01.05 Formulary MHS England Gilteritinib 
08.02.04 Formulary MHS England Glatiramer Acetate Copaxone
01.05.03 Formulary MHS England Golimumab Gastroenterology
08.01.05 Formulary MHS England Ibrutinib Imbruvica
08.01.02 Formulary MHS England Idarubicin Zavedos
08.01.05 Formulary MHS England Idelalisib Zydelig
08.01.01 Formulary MHS England Ifosfamide 
02.05.01 Formulary MHS England Iloprost nebules 
08.01.05 Formulary MHS England Imatinib Gilvec
09.08.01 Restricted Use MHS England Imiglucerase Cerezyme
01.05.03 Formulary MHS England Infliximab 
08.02.04 Formulary MHS England Interferon Alfa 
08.02.04 Formulary MHS England Interferon Alfa Roferon-A
08.02.04 Formulary MHS England Interferon Beta Avonex
08.02.04 Formulary MHS England Interferon Beta Rebif
08.02.04 Formulary MHS England Interferon Beta Betaferon
08.02.04 Formulary MHS England Interferon beta Extavia
08.01.05 Formulary MHS England Ipilimumab Yervoy
08.01.05 Formulary MHS England Irinotecan Hydrochloride 
08.01.05 Formulary MHS England Irinotecan hydrochloride trihydrate  Onivyde
05.02 Non Formulary MHS England Isavuconazole Cresemba
03.07 Non Formulary MHS England Ivacaftor 
03.07 Non Formulary MHS England Ivacaftor with Lumacaftor Orkambi
03.07 Non Formulary MHS England Ivacaftor with Tezacaftor Symkevi
03.07 Non Formulary MHS England Ivacaftor with Tezacaftor and Elexacaftor Kaftrio
05.03.03.01 Formulary MHS England Lamivudine 
08.02.04 Formulary MHS England Lenalidomide  Revlimid
08.01.05 Formulary MHS England Lenvatinib Lenvima
05.01.12 Non Formulary MHS England Levofloxacin Inhaled
08.01.01 Formulary MHS England Lomustine 
08.01.05 Formulary MHS England Lorlatinib 
02.05.01 Formulary MHS England Macitentan 
08.01.01 Formulary MHS England Melphalan 
08.01.03 Formulary MHS England Mercaptopurine Puri-Nethol Xaluprine
08.01 Formulary MHS England Mesna 
08.01.03 Formulary MHS England Methotrexate 
10.02.02 Formulary MHS England Mexiletine 167mg Namuscla
09.08.01 Restricted Use MHS England Migalastat Galafold
09.08.01 Restricted Use MHS England Miglustat Zavesca
08.01.02 Formulary MHS England Mitoxantrone (Mitozantrone) Onkotrone
08.02.01 Formulary MHS England Mycophenolate Mofetil 
08.02.01 Formulary MHS England Mycophenolic acid Myfortic
08.02.04 Formulary MHS England Natalizumab Tysabri
08.01.05 Formulary MHS England Neratinib Nerlynx
08.01.05 Formulary MHS England Nilotinib Tasigna
03.11 Formulary MHS England Nintedanib Vargatef
03.11 Formulary MHS England Nintedanib Ofev
08.02.04 Formulary MHS England Nivolumab Opdivo
14.05.01 Restricted Use MHS England Normal immunoglobulin for Intravenous use 
01.09.01 Formulary MHS England Obeticholic acid Ocaliva
08.02.03 Formulary MHS England Obinutuzumab Gazyvaro
08.02.04 Formulary MHS England Olaparib Lynparza
03.04.02 Formulary MHS England Omalizumab Xolair
08.02.04 Formulary MHS England Osimertinib Tagrisso
08.01.05 Formulary MHS England Oxaliplatin 
08.01.05 Formulary MHS England Paclitaxel 
08.03.04.01 Formulary MHS England Palbociclib Ibrance
05.03.05 Formulary MHS England Palivizumab Synagis
08.01.05 Formulary MHS England Panitumumab Vectibix
08.01.05 Formulary MHS England Panobinostat Farydak
06.05 Non Formulary MHS England Pasireotide 
08.01.05 Formulary MHS England Pazopanib Votrient
08.01 Formulary MHS England Pegaspargase Oncaspar
08.02.04 Formulary MHS England Peginterferon Alfa ViraferonPeg
08.02.04 Formulary MHS England Peginterferon Alfa Pegasys
08.02.04 Formulary MHS England Peginterferon Alfa PegIntron
08.02.04 Formulary MHS England Peginterferon Beta-1a Plegridy
08.01.05 Formulary MHS England Pembrolizumab Keytruda
08.02.04 Formulary MHS England Pembrolizumab Keytruda
08.01.03 Formulary MHS England Pemetrexed Alimta
08.01.05 Formulary MHS England Pentostatin Nipent
08.01.05 Formulary MHS England Pertuzumab Perjeta
03.11 Formulary MHS England pirfenidone Esbriet
08.01.02 Formulary MHS England Pixantrone Pixuvri
09.01.07 Non Formulary MHS England Plerixafor Mozobil
08.01.05 Formulary MHS England Polatuzumab vedotin Polivy
08.02.04 Formulary MHS England Pomalidomide Imnovid
08.01.05 Formulary MHS England Ponatinib Iclusig
05.02 Formulary MHS England Posaconazole (IV) Noxafil
05.02 Formulary MHS England Posaconazole (oral) Noxafil
08.02.02 Formulary MHS England Prednisolone 
08.01.05 Formulary MHS England Procarbazine 
02.11 Formulary MHS England Protein C Concentrate 
08.01.05 Formulary MHS England Ramucirumab Cyramza
08.01.05 Formulary MHS England Regorafenib Stivarga
08.01.05 Formulary MHS England Ribociclib Kisqali
10.02 Non Formulary MHS England Risdiplam 
08.02.03 Formulary MHS England Rituximab Truxima
08.02.03 Formulary MHS England Rituximab MabThera
08.01.05 Formulary MHS England Rucaparib Rubraca
08.01.05 Formulary MHS England Ruxolitinib Jakavi
02.05.01 Formulary MHS England Sildenafil 
08.02.04 Non Formulary MHS England Siponimod Mayzent
08.02.02 Formulary MHS England Sirolimus Rapamune
05.03.03.02 Formulary MHS England Sofosbuvir Sovaldi
05.03.03.02 Formulary MHS England Sofosbuvir and Velpatasvir Epclusa
08.01.05 Formulary MHS England Sorafenib Nexavar
08.01.05 Formulary MHS England Sunitinib Sutent
08.02.02 Formulary MHS England Tacrolimus Prograf
08.02.02 Formulary MHS England Tacrolimus Modigraf
08.02.02 Formulary MHS England Tacrolimus 
08.02.02 Formulary MHS England Tacrolimus  AdoPORT
08.02.02 Formulary MHS England Tacrolimus Advagraf
02.05.01 Formulary MHS England Tadalafil 
08.02.04 Formulary MHS England Talimogene laherparepvac Imlygic
08.01.05 Formulary MHS England Talimogene laherparepvec Imlygic
01.04.02 Restricted Use MHS England Teduglutide 
06.07 Formulary MHS England Temozolomide 
08.01.05 Formulary MHS England Temozolomide Temodal
08.01.05 Non Formulary MHS England Temsirolimus Torisel
05.03.03.01 Formulary MHS England Tenofovir Disproxil 
08.02.04 Formulary MHS England Teriflunomide Aubagio
08.02.04 Formulary MHS England Thalidomide Celgene
08.01.01 Formulary MHS England Thiotepa 
08.01.03 Formulary MHS England Tioguanine Lanvis
05.01.04 Formulary MHS England Tobramycin 
05.01.04 Formulary MHS England Tobramycin inhaler TOBI Podhaler
06.05.02 Formulary MHS England Tolvaptan Samsca
08.01.05 Formulary MHS England Topotecan Hycamtin
08.01.05 Formulary MHS England Trabectedin Yondelis
08.01.05 Formulary MHS England Trametinib Mekinist
08.01.05 Formulary MHS England Trastuzumab Herceptin
08.01.05 Formulary MHS England Trastuzumab emtansine Kadcyla
08.01.01 Formulary MHS England Treosulfan 
08.01.05 Formulary MHS England Tretinoin Vesanoid
08.01.05 Formulary MHS England Trifluridine-tipiracil Lonsurf
13.05.03 Formulary MHS England Ustekinumab 
08.01.05 Formulary MHS England Vandetanib Caprelsa
08.01.05 Formulary MHS England Vemurafenib Zelboraf
08.01.05 Formulary MHS England Venetoclax Venclyxto
08.01.04 Formulary MHS England Vinblastine Sulphate Velbe
08.01.04 Formulary MHS England Vincristine Sulphate Oncovin
08.01.04 Formulary MHS England Vinorelbine Navelbine
02.12 Non Formulary MHS England Volanesorsen Waylivra
09.01.05 Formulary MHS England Vonicog alfa Veyvondi
11.99.99.99 Restricted Use MHS England Voretigene neparvovec Luxturna
05.02 Formulary MHS England Voriconazole 
Shropshire and Telford Local Health Economy